Company Imunosystem Srl with Fiscal Code 30731754
recorded a turnover of 2024 of
40.026,
with a net profit of
-6.289
and having an average number of employees of
3.
The company operates in the field of Alte activitati referitoare la sanatatea umana having the NACE code 8690.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Imunosystem Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
44.958
97.732
69.390
58.915
59.139
54.351
45.019
32.030
54.685
40.026
Total Income - EUR
44.958
97.732
69.391
58.932
59.139
54.351
45.021
32.030
54.685
40.026
Total Expenses - EUR
17.962
62.335
59.550
50.026
56.476
56.174
50.636
39.076
47.743
46.315
Gross Profit/Loss - EUR
26.996
35.397
9.840
8.906
2.664
-1.824
-5.615
-7.046
6.942
-6.289
Net Profit/Loss - EUR
25.647
34.420
7.385
8.317
2.073
-2.352
-6.065
-7.366
6.396
-6.289
Employees
2
3
4
4
4
4
3
2
3
3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -26.4%, from 54.685 euro in the year 2023, to 40.026 euro in 2024.
The Net Profit decreased by -6.360 euro, from 6.396 euro in 2023, to 0 in the last year.
Check the financial reports for the company - Imunosystem Srl
Financial Rating - IMUNOSYSTEM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Imunosystem Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Imunosystem Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Imunosystem Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
14.786 euro in 2024 which includes Inventories of
0 euro, Receivables of
12.573 euro and cash availability of
2.213 euro.
The company's Equity was valued at
7.160 euro, while total Liabilities amounted to
7.626 euro.
Equity decreased by -6.289 euro, from 13.524 euro in 2023, to 7.160 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Imunosystem Srl